Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

HLA-A*02:01 allele is associated with tanshinone-induced cutaneous drug reactions in Chinese population.

Zhu Q, Zhang Y, Xuan J, Yang F, Du B, Chen SA, Yan S, Jiang M, Zhu H, Xiong H, Luo X, Xing Q.

Pharmacogenomics J. 2019 Dec 3. doi: 10.1038/s41397-019-0121-1. [Epub ahead of print]

PMID:
31792370
2.

HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions.

Yan S, Xiong H, Shao F, Zhang W, Yang F, Qi Z, Chen S, He L, Jiang M, Su Y, Zhu H, Qin S, Zhu Q, Luo X, Xing Q.

Pharmacogenomics J. 2019 Jun;19(3):277-285. doi: 10.1038/s41397-018-0051-3. Epub 2018 Sep 20.

PMID:
30237582
3.

HLA-A*02:07 Allele Associates with Clarithromycin-Induced Cutaneous Adverse Drug Reactions in Chinese Patients.

Chen SA, Zhang LR, Yang FP, Yang LL, Yang Y, Chen ZH, Jiang ML, Xiong H, Zhu HZ, Qi Z, Xing QH, Luo XQ.

Basic Clin Pharmacol Toxicol. 2018 Sep;123(3):308-313. doi: 10.1111/bcpt.13011. Epub 2018 Apr 25.

4.

Association between HLA-DRB1*0405, -DQB1*0401 and -DQA1*0303 alleles and lamotrigine-induced cutaneous adverse drug reactions. A pilot case-control study from Japan.

Ito A, Shimada H, Ishikawa K, Takeo N, Hatano Y, Katagiri K, Kohno K, Araki Y, Terao T, Kojima H, Terao C, Eshima N, Fujiwara S.

J Affect Disord. 2015 Jul 1;179:47-50. doi: 10.1016/j.jad.2015.03.018. Epub 2015 Mar 20.

PMID:
25845749
5.

Genetic susceptibility to the cross-reactivity of aromatic antiepileptic drugs-induced cutaneous adverse reactions.

Wang W, Hu FY, Wu XT, An DM, Yan B, Zhou D.

Epilepsy Res. 2014 Aug;108(6):1041-5. doi: 10.1016/j.eplepsyres.2014.03.017. Epub 2014 Apr 8.

PMID:
24856347
6.

Association between HLA-A*3201 allele and oxcarbazepine-induced cutaneous adverse reactions in Eastern Han Chinese population.

Xu J, Shi X, Qiu Y, Zhang Y, Chen S, Shi Y, Deng Y.

Seizure. 2019 Feb;65:25-30. doi: 10.1016/j.seizure.2018.12.011. Epub 2018 Dec 18.

PMID:
30599396
7.

Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population.

An DM, Wu XT, Hu FY, Yan B, Stefan H, Zhou D.

Epilepsy Res. 2010 Dec;92(2-3):226-30. doi: 10.1016/j.eplepsyres.2010.10.006. Epub 2010 Nov 10.

PMID:
21071176
8.

HLA-B*13:01 as a Risk Allele for Antiepileptic Drugs-Induced Cutaneous Adverse Reactions: Higher Risk for Cross-Reactivity?

Min FL, Mao BJ, Zheng ZZ, He N, Fan CX, Cai RY, Wang J, Ou YM, Qin B, Liao WP, Yi YH, Li Z, Shi YW.

Front Neurol. 2019 Jun 11;10:614. doi: 10.3389/fneur.2019.00614. eCollection 2019.

9.

Association between HLA gene polymorphism and cutaneous adverse reactions caused by antiepileptic drugs.

Zhang J, Li X, Su Y, Sun M, Wang J, Hao Y.

Exp Ther Med. 2018 Apr;15(4):3399-3403. doi: 10.3892/etm.2018.5801. Epub 2018 Jan 25.

10.

HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese.

Cao ZH, Wei ZY, Zhu QY, Zhang JY, Yang L, Qin SY, Shao LY, Zhang YT, Xuan JK, Li QL, Xu JH, Xu F, Ma L, Huang HY, Xing QH, Luo XQ.

Pharmacogenomics. 2012 Jul;13(10):1193-201. doi: 10.2217/pgs.12.89.

PMID:
22909208
11.

Levetiracetam-induced cutaneous adverse drug reactions were not associated with HLA genes in a small sample of Chinese patients with epilepsy.

Hu FY, Wang W, Ren JC, An DM, Chen JN, Zhou D.

Epilepsy Res. 2016 Aug;124:12-5. doi: 10.1016/j.eplepsyres.2016.04.008. Epub 2016 May 2.

PMID:
27162008
12.

Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: incidence, features, risk factors and relation to HLA-B alleles.

He N, Min FL, Shi YW, Guo J, Liu XR, Li BM, Zhou JH, Ou YM, Liao JX, Liao WP.

Seizure. 2012 Oct;21(8):614-8. doi: 10.1016/j.seizure.2012.06.014. Epub 2012 Jul 20.

13.

Spectrum of Cutaneous Adverse Reactions to Levetiracetam and Human Leukocyte Antigen Typing in North-Indian Patients.

Ramanujam B, Ihtisham K, Kaur G, Srivastava S, Mehra NK, Khanna N, Singh M, Tripathi M.

J Epilepsy Res. 2016 Dec 31;6(2):87-92. doi: 10.14581/jer.16016. eCollection 2016 Dec.

14.

Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies.

Wu R, Cheng YJ, Zhu LL, Yu L, Zhao XK, Jia M, Wen CH, Long XZ, Tang T, He AJ, Zeng YY, Ma ZF, Zheng Z, Ni MZ, Cai GJ.

Oncotarget. 2016 Dec 6;7(49):81870-81879. doi: 10.18632/oncotarget.13250. Review.

15.

HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.

Fricke-Galindo I, Martínez-Juárez IE, Monroy-Jaramillo N, Jung-Cook H, Falfán-Valencia R, Ortega-Vázquez A, Alonso-Vilatela ME, López-López M.

Pharmacogenomics. 2014;15(15):1881-91. doi: 10.2217/pgs.14.135.

PMID:
25495410
16.

Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis.

Tangamornsuksan W, Lohitnavy M.

JAMA Dermatol. 2018 Apr 1;154(4):441-446. doi: 10.1001/jamadermatol.2017.6484.

17.

HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions.

Yang Y, Chen S, Yang F, Zhang L, Alterovitz G, Zhu H, Xuan J, Yang X, Luo H, Mu J, He L, Luo X, Xing Q.

Pharmacogenomics J. 2017 Dec;17(6):501-505. doi: 10.1038/tpj.2016.61. Epub 2016 Aug 16.

PMID:
27527109
18.

Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population.

Shi YW, Min FL, Liu XR, Zan LX, Gao MM, Yu MJ, Liao WP.

Basic Clin Pharmacol Toxicol. 2011 Jul;109(1):42-6. doi: 10.1111/j.1742-7843.2011.00681.x. Epub 2011 Mar 16.

19.

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.

Ozeki T, Mushiroda T, Yowang A, Takahashi A, Kubo M, Shirakata Y, Ikezawa Z, Iijima M, Shiohara T, Hashimoto K, Kamatani N, Nakamura Y.

Hum Mol Genet. 2011 Mar 1;20(5):1034-41. doi: 10.1093/hmg/ddq537. Epub 2010 Dec 10.

PMID:
21149285
20.

HLA-A*24:02 is associated with metronidazole-induced cutaneous adverse drug reactions in Han Chinese individuals: A pilot case-control study with both HLA gene and T cell receptor repertoire analysis.

Yang F, Jiang M, Zhang W, Qiao Y, Chen SA, Wang D, Zhu H, Zhang J, Qin S, Zhu Q, Lv Y, Xing Q, Luo X.

Basic Clin Pharmacol Toxicol. 2020 Feb;126(2):133-143. doi: 10.1111/bcpt.13315. Epub 2019 Sep 4.

PMID:
31483922

Supplemental Content

Support Center